Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BAG family molecular chaperone regulator 5 (BAG5) is a unique co-chaperone protein of the BAG family, characterized by five tandem BAG domains. BAG5 interacts with the ATPase domain of HSP70/HSC70, acting as a nucleotide exchange factor that enhances protein folding and quality control in cells[2][4][5]. It is especially crucial for proteostasis within junctional membrane complexes (JMCs) in cardiomyocytes, where it ensures proper calcium handling and structural stability[1]. Loss-of-function BAG5 mutations have been shown to cause inherited dilated cardiomyopathy, with disruptions in calcium homeostasis, T-tubule architecture, and increased susceptibility to arrhythmias[1]. BAG5 also interacts with other proteins involved in neuroprotection and mitophagy, making it relevant to neurodegenerative disease mechanisms[4]. There are experimental indications that BAG5 may be a viable target for gene therapy in DCM and possibly other diseases associated with cell stress and protein misfolding[1][4][5].
Gene replacement therapy; Modulation of chaperone activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BAG family molecular chaperone regulator 5 (BAG5).